D. Western Therapeutics Institute, Inc. (4576.T)
JPY 118.0
(3.51%)
JPY 118.0
(3.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -798.55 Million JPY | -161.04% |
| 2022 | -305.91 Million JPY | -78.22% |
| 2021 | -171.64 Million JPY | 35.39% |
| 2020 | -265.67 Million JPY | -326.47% |
| 2019 | 117.31 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -318.79 Million JPY | 6.49% |
| 2024 Q2 | -131.05 Million JPY | 58.89% |
| 2023 Q4 | -340.92 Million JPY | -71.07% |
| 2023 Q3 | -199.28 Million JPY | -26.72% |
| 2023 Q2 | -157.26 Million JPY | -55.58% |
| 2023 Q1 | -101.08 Million JPY | -85.85% |
| 2023 FY | -798.55 Million JPY | -161.04% |
| 2022 FY | -305.91 Million JPY | -78.22% |
| 2022 Q3 | -119.15 Million JPY | 0.0% |
| 2022 Q4 | -54.39 Million JPY | 54.35% |
| 2021 FY | -171.64 Million JPY | 35.39% |
| 2020 FY | -265.67 Million JPY | -326.47% |
| 2019 FY | 117.31 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 233.802% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -60.718% |
| GNI Group Ltd. | 13.1 Billion JPY | 106.092% |
| Linical Co., Ltd. | 725.72 Million JPY | 210.036% |
| Trans Genic Inc. | 89.43 Million JPY | 992.882% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 43.998% |
| Soiken Holdings Inc. | -610 Million JPY | -30.91% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -3.341% |
| AnGes, Inc. | -11.96 Billion JPY | 93.327% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 28.751% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 91.617% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 865.643% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 7.619% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 28.507% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 36.723% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -136.704% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 33.739% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 40.21% |
| PeptiDream Inc. | 6.77 Billion JPY | 111.79% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 58.624% |
| Ribomic Inc. | -1.11 Billion JPY | 28.457% |
| SanBio Company Limited | -4.53 Billion JPY | 82.407% |
| Healios K.K. | -3.37 Billion JPY | 76.367% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 30.866% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 42.695% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 43.082% |
| StemRIM | -2.07 Billion JPY | 61.534% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 165.375% |
| FunPep Company Limited | -994 Million JPY | 19.662% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 10.149% |
| Stella Pharma Corporation | -760.3 Million JPY | -5.032% |
| TMS Co., Ltd. | -943.25 Million JPY | 15.34% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -2.988% |
| Cuorips Inc. | -588.48 Million JPY | -35.697% |
| K Pharma,Inc. | 366.05 Million JPY | 318.151% |
| Takara Bio Inc. | 3 Billion JPY | 126.592% |
| ReproCELL Incorporated | -409.29 Million JPY | -95.107% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 7318.277% |
| StemCell Institute Inc. | 413.75 Million JPY | 293.001% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 652.609% |
| CellSeed Inc. | -697.77 Million JPY | -14.443% |